- $121.93bn
- $140.83bn
- £32.67bn
- 98
- 63
- 99
- 99
REG - GlaxoSmithKline PLC - GSK and Alector collaboration in immuno-neurology
AnnouncementREG - GlaxoSmithKline PLC - Elliott Advisors (UK) letter to GSK
AnnouncementREG - GlaxoSmithKline PLC - Total Voting Rights
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - GSK to deliver step-change in growth & performance
AnnouncementREG - GlaxoSmithKline PLC - ViiV/Halozyme sign exclusive licensing agreement
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - GlaxoSmithKline PLC - GSK and iTeos announce collaboration for EOS-448
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - BMO UK High Inc Tst BMO UK High Inc-BHIB BMO UK High Inc-BHIU - Portfolio Update
AnnouncementREG - GlaxoSmithKline PLC - GSK recommend ADR holders reject mini-tender offer
AnnouncementREG - GlaxoSmithKline PLC - Total Voting Rights
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - GSK/Vir Sotrovimab FDA Emergency Use Authorization
AnnouncementREG - GlaxoSmithKline PLC - Sanofi and GSK initiate new Phase 3 clinical study
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - GSK/VIR sotrovimab receives positive EMA opinion
Announcement